Thomas Reiberger
@ReibergerThomas
Followers
2K
Following
6K
Media
461
Statuses
1K
Professor of Hepatology @MedUni_Wien Director CD-Lab for #PortalHypertension & #LiverFibrosis Adjunct PI @CeMM_News Head @CrgMOTION Secretary @BavenoCoop
Vienna, Austria
Joined July 2021
This is the most important #Liver #Cirrhosis conference in the next 5 Years : ⏩⏩ #BavenoVIII @BavenoCoop ⏪⏪ #PortalHypertension Guidelines #CSPH Everything U Need #EtiologicCure #Recompensation #SteatoticLiverDisease #ArLD #MASH
#NITs #LiverStiffness #SpleenStiffness #TIPS
1
20
72
Treatment response to #bulevirtide is linked to amelioration of #PortalHypertension in patients with chronic #HepatitisD
@JHEP_Reports 🔗 https://t.co/e1J9wTlvBd
1
8
16
🚨Pancreatic enzyme⏫are frequent in Acute-on Chronic #LiverFailure #ACLF 👉#Lipase ≥3⃣xULN at D7 predicts mortality 🤔Lipase in ACLF: ♻️circulatory &🫘renal dysfunction. 💡Lipase✅simple bedside 🛌biomarker ⛳️highrisk #ACLF Dr @georgkramer AnnHepatol 🔗 https://t.co/S4U0JgDcRj
1
8
33
🚨 Updated @BavenoCoop "Rule-of-5" Figure by the #ANTICIPATE ±NASH team 📕in @JHepatology 🔗 https://t.co/yy92JSulCj
1
37
85
0
16
49
Intestinal blood vessel macrophages and gut-vascular barrier (#GVB) dysfunction in #cirrhosis Increased Gut Monocyte influx (#S100A8A9) LP2 Macs (#HES1 #CD163) ↘️ in #cirrhosis 🔂Bacterial🦠 translocation 📘Smets L, Viola MF, Boesch M @Gut_BMJ 2025 🔗 https://t.co/PwLwJ3S24Q
1
3
17
👀 at the AUROCs achieved by #2DSWE 2D shear wave #elastography vs. #MRE and #VCTE for the assessment of #Liver #Fibrosis in #Steatotic Liver Disease (#MASLD #MetALD) @NatRevGastroHep 🔗 https://t.co/o9g5tYC9ey
0
2
10
Steatotic #Liver Disease in the Western World is mostly caused by #MetALD Junk Food🍔 Sugar/Sweets/Sodas🍫🥤 Alcohol 🍺🍷 @NatRevGastroHep 🔗 https://t.co/o9g5tYC9ey
4
23
71
Feasibility and Safety of #Cytosorb Application in Patients With Acute Liver Failure #ALF Read @LiverInt
https://t.co/Oad63wMdG9
onlinelibrary.wiley.com
Background and Aims Acute liver failure (ALF) is a rare, life-threatening condition with high mortality and limited therapeutic options beyond liver transplantation. Cytosorb adsorber can be easily...
1
1
8
#HPB #Surgery 🫂Multi-Society and🤝Multi-Disciplinary #Consensus on Peri- and Postoperative Management Following #LiverResection The E-AHPBA – ESSO – Innsbruck consensus 📕 HBP Journal 🔗 https://t.co/TsGPIgB04Z
0
3
11
Katharina Bonitz presenting @AASLDtweets Liver Meeting #TLM25 on the impact if #Anticoagulation antiXa #Edoxaban improves #PortalHypertension Anti-Inflammatory Mechanisms via PAR2-Macrophages and downregulating #NFkB
0
3
17
Linerixibat in patients with primary biliary cholangitis #PBC and cholestatic #pruritus (GLISTEN) - a P3-RCT @LancetGastroHep
https://t.co/pr9a4SHqTr
thelancet.com
Linerixibat significantly improved pruritus versus placebo, supporting its potential to address a major symptom of PBC. An expected increase in diarrhoea in linerixibat-treated patients was observed.
0
0
7
🚨Just one month away‼️ Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷 🗓️ Dec 4–5 @ CNAM 💳 Onsite €150 | 💻 Online FREE 👉 Organized by EURO-VALDIG NET & FILFOIE 🔗 Registration -> https://t.co/i4YgLSeDHA 📘 Full program below 👇 #LiverTwitter
0
9
11
#LiverX Prevalence of #Steatosis and #Fibrosis in🇦🇹#Austria by🩸blood-based and #Elastography 🔊based non-invasive tests (#NITs) 📕full study @AGA_CGH
https://t.co/hlrNsO9ncM
0
6
21
#Alcohol #Cirrhosis
#Naltrexon and #Acamprosat improve outcomes in patients with alcohol-related cirrhosis: ⏬ Decompensation ⏬ HCC ⏬ Mortalty Niu @LiverInt 2025
onlinelibrary.wiley.com
Background and Aims The effectiveness and safety of medications for alcohol use disorder (MAUD) in treating alcohol-associated cirrhosis have not been fully elucidated. This study aims to explore...
0
12
27
NEW & now online in @HEP_Journal: #AASLD & #IDSA Practice Guideline on the Treatment of Chronic #HepatitisB. Read the NEW Guideline in HEPATOLOGY here: https://t.co/vqQcFe2ATn Dig deeper with more resources to read, learn, and implement: https://t.co/WGj7JHw5Li
0
3
7
After 2 months of paternity leave - returning to work tomorrow. will miss the time with my happy baby girl
2
0
50
Important Deadlines for #BavenoVIII ‼️ 💶 Early registration: 15 Dec 2025 🪶 Abstract submission: 15 Jan 2026 📄 Satellite programmes & speakers: 15 Jan 2026 📦 Sponsor material delivery at venue: 20 Mar 2026 Stay tuned for updates -> 🔗 https://t.co/s5sCEyshSe
#LiverTwitter
1
5
9